Tirzepatide: A dual action approach to weight reduction and glycemic control in type 2 diabetes mellitus

Tirzepatide: A dual action approach to weight reduction and glycemic control in type 2 diabetes mellitus

Tirzepatide, a dual GIP and GLP-1 receptor agonist, is an innovative therapy for type 2 diabetes mellitus (T2DM) and obesity. By stimulating insulin secretion, inhibiting glucagon release, slowing gastric emptying, and enhancing satiety, it offers superior glycemic control and weight reduction compa...

Full description

Saved in:
Bibliographic Details
Main Authors: Princy Domnic Dsouza, Sai Phalguna Prakash Chitralu, Ramish Khan, Sanatkumar Bharamu Nyamagoud
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:MGM Journal of Medical Sciences
Subjects:
glucagon-like peptide-1 (glp-1)
glucose-dependent insulinotropic polypeptide (gip)
non-alcoholic fatty liver disease (nafld)
obesity
pharmacodynamics
pharmacokinetics
polycystic ovarian syndrome (pcos)
tirzepatide
type 2 diabetes mellitus (t2dm)
Online Access:https://doi.org/10.4103/mgmj.mgmj_386_24
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.4103/mgmj.mgmj_386_24

Similar Items